These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 9366524

  • 1. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.
    Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524
    [Abstract] [Full Text] [Related]

  • 2. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.
    Oncogene; 2001 Jun 07; 20(26):3363-75. PubMed ID: 11423987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells.
    Yang YM, Dolan LR, Ronai Z.
    Oncogene; 1996 May 16; 12(10):2223-33. PubMed ID: 8668349
    [Abstract] [Full Text] [Related]

  • 6. Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy.
    Jean D, Bar-Eli M.
    Crit Rev Immunol; 2001 May 16; 21(1-3):275-86. PubMed ID: 11642609
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M.
    Cancer Res; 2002 Sep 01; 62(17):5106-14. PubMed ID: 12208768
    [Abstract] [Full Text] [Related]

  • 9. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
    Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M.
    Am J Pathol; 1997 Oct 01; 151(4):1105-13. PubMed ID: 9327744
    [Abstract] [Full Text] [Related]

  • 10. CREB and its associated proteins act as survival factors for human melanoma cells.
    Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M.
    J Biol Chem; 1998 Sep 18; 273(38):24884-90. PubMed ID: 9733794
    [Abstract] [Full Text] [Related]

  • 11. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
    McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M.
    Clin Cancer Res; 2003 Dec 15; 9(17):6560-6. PubMed ID: 14695161
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M.
    J Cell Physiol; 1997 Nov 15; 173(2):275-8. PubMed ID: 9365536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
    Elkin M, Reich R, Nagler A, Aingorn E, Pines M, de-Groot N, Hochberg A, Vlodavsky I.
    Clin Cancer Res; 1999 Aug 15; 5(8):1982-8. PubMed ID: 10473075
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 15; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 18. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.
    Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M.
    Cancer Res; 1996 Dec 15; 56(24):5678-83. PubMed ID: 8971175
    [Abstract] [Full Text] [Related]

  • 19. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2000 May 15; 6(5):2104-19. PubMed ID: 10815938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.